Canadian Cancer Trials Group Bulletins


Recent Publication

The primary publication for MAP.1 -- A Randomized Feasibility Study of Letrozole in Postmenopausal Women at Increased Risk for Development of Breast Cancer as Evidenced by High Breast Density -- was recently published in Breast Cancer Research and Treatment.

Cigler T, Tu D, Yaffe MJ, Findlay B, Verma S, Johnston D, Richardson H, Hu H, Qi S, Goss PE. A randomized, placebo-controlled trial (Canadian Cancer Trials Group MAP1) examining the effects of letrozole on mammographic breast density and other end organs in postmenopausal women (ONLINE). Breast Cancer Res Treat 2009.